首页> 外国专利> L1 Novel antimicrobial peptide derived from Ribosomal Protein L1 of Helicobacter pylori and use thereof

L1 Novel antimicrobial peptide derived from Ribosomal Protein L1 of Helicobacter pylori and use thereof

机译:L1来源于幽门螺杆菌的核糖体蛋白L1的新型抗菌肽及其用途

摘要

The present invention relates to a novel antibiotic peptide derived from a ribosomal protein L1 of Helicobacter pylori and its use, and specifically relates to a novel antibiotic peptide derived from Helicobacter pylori by substituting proline for phenylalanine, which is the 12th amino acid of the peptide consisting of the amino acid sequence shown in SEQ ID NO: To thereby synthesize a novel peptide represented by SEQ. ID. NO. 4, and by confirming that the novel peptide exhibited significant antimicrobial activity and no cytotoxicity, the novel peptide can be used as an effective ingredient of a natural antimicrobial agent.
机译:本发明涉及一种源自幽门螺杆菌的核糖体蛋白L1的新型抗生素肽及其用途,特别涉及一种通过用脯氨酸代替苯丙氨酸来衍生自幽门螺杆菌的新型抗生素肽,苯丙氨酸是该肽的第12个氨基酸。由此合成SEQ ID NO:1所示氨基酸序列的肽。 ID。没有。如图4所示,并且通过确认该新型肽表现出显着的抗微生物活性并且没有细胞毒性,该新型肽可以用作天然抗微生物剂的有效成分。

著录项

  • 公开/公告号KR101583025B1

    专利类型

  • 公开/公告日2016-01-07

    原文格式PDF

  • 申请/专利权人 조선대학교 산학협력단;

    申请/专利号KR20130001074

  • 发明设计人 박윤경;이종국;

    申请日2013-01-04

  • 分类号C07K7/08;A61K38/10;A61P31/04;

  • 国家 KR

  • 入库时间 2022-08-21 14:13:11

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号